Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,100.00GBp
11:01am EDT
Price Change (% chg)

-12.00p (-1.08%)
Prev Close
1,112.00p
Open
1,114.00p
Day's High
1,117.00p
Day's Low
1,096.00p
Volume
225,307
Avg. Vol
238,012
52-wk High
1,127.00p
52-wk Low
696.00p

HIK.L

Chart for HIK.L

About

Hikma Pharmaceuticals PLC is engaged in the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. The Company operates in three business segments: Branded, Injectables, and Generics. The majority of its operations are... (more)

Overall

Beta: 0.70
Market Cap (Mil.): £2,213.90
Shares Outstanding (Mil.): 197.94
Dividend: 6.56
Yield (%): 0.94

Financials

  HIK.L Industry Sector
P/E (TTM): 33.44 38.06 37.87
EPS (TTM): 0.33 -- --
ROI: 8.89 19.42 18.70
ROE: 12.47 20.10 19.53
Search Stocks

UPDATE 1-Hikma raises full-year revenue forecast again

* Shares up as much as 9 pct (Adds analysts' comments, details; updates share movement)

08 Jul 2013

BRIEF-Hikma signs marketing deal with Theravance

LONDON, July 1 - Hikma Pharmaceuticals PLC : * Signing of an exclusive commercialisation agreement with theravance, inc for

01 Jul 2013

Hikma expects revenue to rise 13 pct in 2013

May 16 - Hikma Pharmaceuticals Plc raised its full-year revenue forecast, saying its generic antibiotic doxycycline was generating revenue ahead of its expectations.

16 May 2013

BRIEF-Hikma Pharmaceutical expects group revenue to grow by around 13% in 2013

LONDON, May 16 - Hikma Pharmaceuticals PLC : * Hikma pharmaceutical - interim management statement * Branded and injectables businesses are on track to meet our current FY

16 May 2013

Hikma Pharma rejects sale of injectables business

LONDON, April 17 - Hikma Pharmaceuticals said on Wednesday it would keep its fast-growing injectables business after weighing up a number of unsolicited approaches for the unit.

17 Apr 2013

BRIEF-Hikma to keep global injectables business

LONDON, April 17 - Hikma Pharmaceuticals PLC : * CORRECTED-HIKMA PHARMACEUTICALS PLC - DETERMINED THAT GLOBAL

17 Apr 2013

Injectables business boosts Hikma Pharma's profit

March 13 - Hikma Pharmaceuticals Plc reported a 19 percent rise in full-year profit, helped by strong growth in its lucrative injectables business, which has drawn interest from several bidders.

13 Mar 2013

BRIEF-Hikma Pharmaceuticals expects revenue to grow 10 percent in 2013

LONDON, March 13 - Hikma Pharmaceuticals PLC : * Auto alert - Hikma Pharmaceuticals Plc final dividend 0.10 usd per

13 Mar 2013

UPDATE 2-Hikma eyes options for injectables business, shares rise

* Says got expressions of interest for injectables business

01 Mar 2013

Hikma says considering strategic options for injectables business

March 1 - Hikma Pharmaceuticals Plc said it reviewing options for its injectables business.

01 Mar 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$472.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks